Monitoring SIV Reservoirs with Whole Body immunoPET
使用全身免疫 PET 监测 SIV 储库
基本信息
- 批准号:9301446
- 负责人:
- 金额:$ 159.08万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2014
- 资助国家:美国
- 起止时间:2014-07-15 至 2019-06-30
- 项目状态:已结题
- 来源:
- 关键词:Acquired Immunodeficiency SyndromeAcuteAddressAffectAffinityAnatomyAnimal ModelAnti-Retroviral AgentsAntiviral AgentsBiomedical EngineeringBiopsyBloodCD4 Positive T LymphocytesCell LineageCellsClinicClinicalCoupledDevelopmentDisease ProgressionDrug KineticsExposure toFoundationsGoalsHIVHIV InfectionsHumanImageImaging TechniquesImmuneIn SituIn VitroIndividualInfectionInfection preventionInterruptionKineticsLabelLymphoid TissueMacacaMacaca mulattaMapsMeasuresMetabolismMethodsModelingMonitorMonkeysMonoclonal AntibodiesNatureOrganOutcomePathologyPatientsPatternPharmaceutical PreparationsPharmacodynamicsPlasmaPositron-Emission TomographyPreventive measurePrimatesProcessProtocols documentationRadionuclide ImagingRegimenResidual stateRouteSIVSamplingSignal TransductionSiteTechnetium Tc 99m ciprofloxacinTechniquesTestingTherapeuticTimeTissue BanksUniversitiesVaccinesVaginaVariantViralViral Load resultViral ProteinsViral reservoirVirusVirus DiseasesVirus ReplicationX-Ray Computed Tomographyantiretroviral therapybasebody mapclinical applicationdesignimaging modalityimmune activationimprovedin vivoinnovationminimally invasivenonhuman primatenovelnovel strategiespublic health relevancerectalsimian human immunodeficiency virustooltransmission processviral RNAviral detectionvirus pathogenesis
项目摘要
DESCRIPTION (provided by applicant):
With the advent of novel anti-retroviral therapies, the prospect of potentially eliminating HIV from infected patients may become an achievable goal. However, such goal will require new tools with greater sensitivity than currently available to monitor the progress of such therapy, no only in blood but also in organs that do harbor such reservoirs and sites of residual viral replication in vivo. In addition, identifying early seeding of viral reservoirs during acute infecton relative to the route of transmission and disease progression may open novel directions for chemotherapeutic or immune barriers to contain the new virus infection foyers and generalized dissemination of the infection with seeding of viral reservoirs. To harness such early viral dynamics and account for the natural individual variation that exists for such dynamics, there is a need to understand the dissemination patterns of HIV infection following mucosal transmission, the primary transmission mode of infection worldwide. However, the tools currently available to monitor such viral processes are either indirect or relatively invasive and clearly impractical for the human clinic. Even when one uses the nonhuman primate model of AIDS, understanding the viral dynamics in real time is challenging and prohibitively expensive if one chooses to perform serial sacrifices, not to mention fraught by a high degree of variability between individuals. In this project, we propose to optimize our established immuno-positron emission tomography (PET) with simultaneous X-ray computed tomography (CT), to determine real-time whole body maps of simian immunodeficiency virus replication sites in vivo to chart out the total body replication sites of SIV in vivo and determine viral dynamics and sites of residual viral replication during antiretroviral therapy. Thus we propose to determine the anatomic SIV viral dynamics following infection via the IV, rectal and vaginal route to determine the consecutive major sites of viral replication in vivo, which will be confirmed via targeted tissue collections. Next we will compare 2 combination ART therapies for reducing viral reservoirs and document residual foyers of replication in vivo as well as determine which such reservoirs might be fueling the viral resurgence after interruption of ART in vivo. We submit that these studies wil provide critical information for the design of HIV eradication strategies in human HIV infection.
描述(由申请人提供):
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
PHILIP J SANTANGELO其他文献
PHILIP J SANTANGELO的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('PHILIP J SANTANGELO', 18)}}的其他基金
mRNA-encoded Cas13 as a pan-respiratory antiviral
mRNA 编码的 Cas13 作为泛呼吸道抗病毒药物
- 批准号:
10637171 - 财政年份:2023
- 资助金额:
$ 159.08万 - 项目类别:
Durable Vaginal Protection from HIV via mRNA expression of BNABS
通过 BNABS 的 mRNA 表达持久保护阴道免受 HIV 侵害
- 批准号:
10458277 - 财政年份:2020
- 资助金额:
$ 159.08万 - 项目类别:
Durable Vaginal Protection from HIV via mRNA expression of BNABS
通过 BNABS 的 mRNA 表达持久保护阴道免受 HIV 侵害
- 批准号:
10461959 - 财政年份:2020
- 资助金额:
$ 159.08万 - 项目类别:
Identification of SIV replication and reservoirs in the CNS
CNS 中 SIV 复制和储存库的识别
- 批准号:
10266819 - 财政年份:2020
- 资助金额:
$ 159.08万 - 项目类别:
Identification of SIV replication and reservoirs in the CNS
CNS 中 SIV 复制和储存库的识别
- 批准号:
10669027 - 财政年份:2020
- 资助金额:
$ 159.08万 - 项目类别:
Identification of SIV replication and reservoirs in the CNS
CNS 中 SIV 复制和储存库的识别
- 批准号:
10452609 - 财政年份:2020
- 资助金额:
$ 159.08万 - 项目类别:
Durable vaginal protection from HIV via mRNA expression of bnAbs
通过 bnAb 的 mRNA 表达持久保护阴道免受 HIV 侵害
- 批准号:
10160529 - 财政年份:2020
- 资助金额:
$ 159.08万 - 项目类别:
Whole body to single cell analysis of the HIV reservoir
HIV 储存库的全身到单细胞分析
- 批准号:
10335265 - 财政年份:2018
- 资助金额:
$ 159.08万 - 项目类别:
Structural Investigations Of Macromolecular Complexes Critical To hRSV Life Cycle
对 hRSV 生命周期至关重要的大分子复合物的结构研究
- 批准号:
9037932 - 财政年份:2016
- 资助金额:
$ 159.08万 - 项目类别:
Structural Investigations Of Macromolecular Complexes Critical To hRSV Life Cycle
对 hRSV 生命周期至关重要的大分子复合物的结构研究
- 批准号:
9195113 - 财政年份:2016
- 资助金额:
$ 159.08万 - 项目类别:
相似海外基金
Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
- 批准号:
MR/Y009568/1 - 财政年份:2024
- 资助金额:
$ 159.08万 - 项目类别:
Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
- 批准号:
10090332 - 财政年份:2024
- 资助金额:
$ 159.08万 - 项目类别:
Collaborative R&D
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
- 批准号:
MR/X02329X/1 - 财政年份:2024
- 资助金额:
$ 159.08万 - 项目类别:
Fellowship
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
- 批准号:
MR/X021882/1 - 财政年份:2024
- 资助金额:
$ 159.08万 - 项目类别:
Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
- 批准号:
MR/X029557/1 - 财政年份:2024
- 资助金额:
$ 159.08万 - 项目类别:
Research Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
- 批准号:
EP/Y003527/1 - 财政年份:2024
- 资助金额:
$ 159.08万 - 项目类别:
Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
- 批准号:
EP/Y030338/1 - 财政年份:2024
- 资助金额:
$ 159.08万 - 项目类别:
Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
- 批准号:
2312694 - 财政年份:2024
- 资助金额:
$ 159.08万 - 项目类别:
Standard Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
- 批准号:
24K19395 - 财政年份:2024
- 资助金额:
$ 159.08万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Acute human gingivitis systems biology
人类急性牙龈炎系统生物学
- 批准号:
484000 - 财政年份:2023
- 资助金额:
$ 159.08万 - 项目类别:
Operating Grants














{{item.name}}会员




